UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
____________________
FORM SD
Specialized Disclosure Report
____________________
Pulse Biosciences, Inc.
(Exact name of registrant as specified in its charter)
____________________
|
|
|
|
|
Delaware |
| 001-37744 |
| 46-5696597 |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
3957 Point Eden Way
Hayward, California 94545
(Address of principal executive offices, including zip code)
Sandra A. Gardiner
Chief Financial Officer, Executive Vice President of Finance
and Administration, and Treasurer
(510) 906-4600
(Name and telephone number, including area code, of the person to contact in connection with this report)
____________________
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
|
|
|
☒ |
| Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2021 |
Section 1. Conflict minerals disclsosure
Item 1.01 Conflict Minerals Disclosure and Report
A copy of Pulse Biosciences, Inc.’s (the “Company’s”) Conflict Minerals Report for the reporting period January 1, 2021 to December 31, 2021 is provided as Exhibit 1.01 hereto and is publicly available at www.pulsebiosciences.com.
Item 1.02 Exhibit
In accordance with Rule 13p-1, and this Form SD, the Company is hereby filing its Conflict Minerals Report for the calendar year ended December 31, 2021 as Exhibit 1.01 to this report.
Section 2. Exhibits
The following exhibits are filed as part of this report:
Item 2.01 Exhibits
Exhibit 1.01 — 2021 Conflict Minerals Report of Pulse Biosciences, Inc. as required by Items 1.01 and 1.02 of this Form SD.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 31, 2022
